Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 26
Item hits:
Issue DateTitleAuthor(s)
16-Jan-2018Corrigendum: Inhibitor selectivity for cyclin-dependent kinase 7: a structural, thermodynamic, and modelling studyHazel, P; Kroll, SHB; Bondke, A; Barbazanges, M; Patel, H, et al
10-Apr-2013miR-23b regulates cytoskeletal remodeling, motility and metastasis by directly targeting multiple transcriptsPellegrino, L; Stebbing, J; Braga, VM; Frampton, AE; Jacob, J, et al
28-Jan-2019Towards multiplexed near-infrared cellular imaging using gold nanostar arrays with tunable fluorescence enhancementTheodorou, I; Ruenraroengsak, P; Carter, D; Jiang, Q; Yague, E, et al
20-Aug-2016ICEC0942, an orally bioavailable selective inhibitor of CDK7 for breast cancerAli, S; Patel, H; Periyasamy, M; Bondke, A; Slafer, BW, et al
1-Nov-2017IPET study: an FLT-PET window study to assess the activity of the steroid sulfatase inhibitor irosustat in early breast cancerPalmieri, C; Szydlo, R; Miller, M; Barker, L; Patel, NH, et al
1-Jan-2018Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trialsAlberro, JA; Ballester, B; Deulofeu, P; Fabregas, R; Fraile, M, et al
11-Jun-2014Nicastrin and Notch4 drive endocrine therapy resistance and epithelial to mesenchymal transition in MCF7 breast cancer cellsLombardo, Y; Faronato, M; Filipovic, A; Vircillo, V; Magnani, L, et al
19-May-2015Apoptosis inhibitor TRIAP1 is a novel effector of drug resistanceAdams, C; Cazzanelli, G; Rasul, S; Hitchinson, B; Hu, Y, et al
1-May-2019Oncogenic EP300 can be targeted with inhibitors of aldo-keto reductasesMahmud, Z; Asaduzzaman, M; Kumar, U; Masrour, N; Jugov, R, et al
22-May-2012Viable circulating tumour cell detection using multiplex RNA in situ hybridisation predicts progression-free survival in metastatic breast cancer patientsPayne, RE; Wang, F; Su, N; Krell, J; Zebrowski, A, et al